Send us Fan Mail

In this episode, Rachael interviews a world renowned physician and clinical trialist, open to sharing details about what's happening behind the scenes in the diabetes research world when it comes to new therapies for T1D, but at a global level.

Her guest? Leading scientist and pediatric endocrinologist from the University of Florida, Dr. Michael Haller. He answers questions about IV infusions of Teplizumab and various forms of anti-thymocyte globulin (ATG). They talk about a clinical trial called "Safeguard", which has been fast-tracked by the FDA, aiming to study a different human version of anti-thymocyte globulin (ATG).

Dr. Haller also opens up on details surrounding events that occurred during the American Diabetes Association (ADA) Annual Scientific Sessions in June 2026, in New Orleans, Louisiana. The story actually went VIRAL in the press; even making it to the front page of the New York Times. This was after several very prominent scientists were escorted out of the conference for distributing peer-reviewed published journal articles. Since that time, a formal boycott on the ADA has been called, asking for an internal review of the events that occurred. Now, over 1000 physicians and scientific leaders have signed the boycott, yet nothing has changed. So the diabetes community continues to search for answers.

Rachael asks Dr. Haller, "What exactly happened since you were there?" And if this boycott is honored, "Will it improve the lives of people living with diabetes?" This is the FIRST time any physician has freely spoken on camera about what actually happened, so it's an episode you WON'T want to miss.

https://youtube.com/@thediabetescollective?si=6gvVGtd5Um9XSb4u

https://www.instagram.com/thediabetescollective?igsh=bGI5bno2NnUwNmp3&utm_source=q

https://www.facebook.com/share/14mrAd3kbVj/?mibextid=wwXIfr

https://www.tiktok.com/@thediabetescollective?_r=1&_t=ZT-97f3bZc8GU9

Send us Fan Mail

In this episode, Rachael podcasts live at the inaugural Breakthrough T1D Research Clinical Congress in Philadelphia, October 9-11, 2026. She interviews Dr. Aaron Kowalski, the CEO of Breakthrough T1D (formerly JDRF), about the organization and how they are funding and supporting research that ultimately will lead to cell therapies. Aaron describes details about the Vertex clinical trial, which is evaluating if infusing stem cell-derived islet cells in people living with type 1 will relieve them of their insulin dependence. It turns out, it's already worked in 10 people! And now we are just waiting for the trial to finish and release results on 38 more. Aaron is a person living with Type 1 diabetes, and even helped bring the first insulin pumps to market. Yet ironically, he states, "I believe I'll be taking my pump off" in this lifetime. Aaron even describes what the launch of commercially available cell therapies might realistically look like and provides an estimated timeline.

If you're someone that has lost hope or ever doubted if "the cure for type 1 is almost here?", then this episode breaks it down clearly so you can understand and feel confident that we are very very close and living in a Renaissance age for Type 1 diabetes.

https://youtube.com/@thediabetescollective?si=6gvVGtd5Um9XSb4u

https://www.instagram.com/thediabetescollective?igsh=bGI5bno2NnUwNmp3&utm_source=q

https://www.facebook.com/share/14mrAd3kbVj/?mibextid=wwXIfr

https://www.tiktok.com/@thediabetescollective?_r=1&_t=ZT-97f3bZc8GU9

Send us Fan Mail

In this episode, Rachael kicks off season 2 of the Diabetes Diaries, at the Inaugural Breakthrough T1D Clinical & Research Congress (CRC2026), happening October 9 - 11th, 2026 in Philadelphia, Pennsylvania. This was a Live podcast on site, where over 1000 medical leaders from over 31 countries, gathered to present and share research with the mission of ending Type 1 diabetes. Rachael has a candid interview with the chief medical officer of the organization, and pediatric endocrinologist, Dr. Thomas Danne. Danne has been a practicing physician for over 40 years and has trained and practiced in Germany, serving as president of both the International Society for Pediatric and Adolescent Diabetes and the German Diabetes Association. He answers questions about what "breakthroughs" are coming for treating type 1, and what that will realistically look like once rolled out. Dr. Danne describes cell therapy and who it's intended for, plus details that the organization has for a future where people with Diabetes might live insulin free.

To any person living with Type 1, or a parent whose child was recently diagnosed, this is a conversation about plans for the next generation that you won't want to miss.

https://youtube.com/@thediabetescollective?si=6gvVGtd5Um9XSb4u

https://www.instagram.com/thediabetescollective?igsh=bGI5bno2NnUwNmp3&utm_source=q

https://www.facebook.com/share/14mrAd3kbVj/?mibextid=wwXIfr

https://www.tiktok.com/@thediabetescollective?_r=1&_t=ZT-97f3bZc8GU9